Skip to content

Author

Na Chen

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine

Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic inflammatory disorder of the airways characterized by substantial morbidity, disability, and mortality. It poses a significant global public health burden. Conventional therapies for COPD, which mainly rely on bronchodilators and inhaled cortico...

Guang-Wei Chen, Hai-Shun Yang, Wei-Han Sun et al. · 0 citations
Open access Sep 2026

Worenine attenuates pulmonary fibrosis potentially through modulation of PBK/SRC-associated TGF-β1/Smad and NF-κB signaling pathways.

Worenine attenuates experimental pulmonary fibrosis, potentially through modulation of PBK/SRC-associated signaling and the TGF-β1/Smad, ERK, and NF-κB pathways, and provide a rationale for further investigation of Worenine as a potential therapeutic candidate for PF.

Ya-Fang Li, Na Chen, Yi-Jie Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.